SEC Filing Update: #CLDX Celldex Therapeutics, Inc. : $41.48

Sector: Healthcare | YTD: 🔼+ 53.52% The SEC disclosed Today (14-AUG-2026) that PRICE T ROWE ASSOCIATES INC MD has INCREASED #CLDX Shares by 0.02% 🟢 * Previous Holdings: 4.69M Shares * Current Holdings: 4.69M Shares * Increase+964.00 * Increased(%)+0.02% * Ownership: 6.0% * Estimated Investment Value: $40.19K https://www.thinksabio.com/reports/isr/CLDX The quarterly average prices of #CLDX: Q3 2025: $23.18 Q4 2025: $26.35 Q1 2026: $27.27